In a large-scale study of 3281 hospitalized COVID-19 patients, it was found that 82% of these patients had elevated levels of one of the three biomarkers that reflect the pathobiological axes of myocardial injury, coagulation, and inflammation (cardiac troponin, D-dimer and CRP, respectively). This evidence concerns the gene CRP and COVID-19.